shadow_tr

Welcome

Education

Research

Clinical Services

Personnel

Conferences

Annual Lectureships

News


Tulane University Health Sciences
Department of Pathology and Laboratory Medicine
1430 Tulane Avenue SL-79
New Orleans, Louisiana
70112-2699
Phone 504-988-5224
Fax 504-988-7389
Email tulpath@tulane.edu

Andrew Blake Sholl, MD

Andrew B. Sholl, MD


Assistant Professor

 

Education:


Fellowship:

  • 2012-2013 The University of Texas, Houston, TX
    MD Anderson Cancer Center
    Cytopathology

Post-Graduate:

  • 2008-2012 University of Colorado Denver, Aurora, CO
    Pathology Residency, Department of Pathology
    AP/CP   

Graduate:

  • 2004-2008 Tulane University, New Orleans, LA
    School of Medicine
    M.D.               

Undergraduate:

  • 2000-2004, Bucknell University, Lewisburg, PA
    College of Arts & Sciences
    B.S.

Positions and Appointments:

  • Director of Autopsy Pathology, Tulane University School of Medicine, 2013 - Present
  • Chief Resident, University of Colorado, Denverm 2011-12

 

Specialty Certification:

  • Diplomate of the American Board of Pathology in Anatomic & Clinical Pathology, 2012
  • Diplomate of the American Board of Pathology in Cytopathology, 2013

 

Awards, Honors, and Memberships in Honor Societies:

  • T2 Best Tutorial Facilitator Award, Tulane University School of Medicine, 2016
  • Medical Student Teaching Award, University of Colorado Denver, 2012
  • Medical Student Teaching Award, University of Colorado Denver, 2011

 

Membership in Professional and Scientific Societies:

  • College of American Pathologists (CAP)
  • American Society of Clinical Pathology (ASCP)
  • American Society of Cytopathology (ASC)
  • Unites States and Canadian Academy of Pathology (USCAP)

 

Publications

1. Nelson RE, Ahmad H, Hildrew DM, Lawlor CM, Aslam R, Sholl A, Kandil E. Thyroglossal Duct Remnant with Follicular Hyperplasia Presenting After Total Thyroidectomy. Ochsner J. 2016 Summer;16(2):154-7. PubMed PMID: 27303226; PubMed Central PMCID: PMC4896660.

2. Bhatia P, Deniwar A, Mohamed HE, Sholl A, Murad F, Aslam R, Kandil E. Vanishing tumors of thyroid: histological variations after fine needle aspiration. Gland Surg. 2016 Jun;5(3):270-7. doi: 10.21037/gs.2016.01.05. PubMed PMID: 27294033; PubMed Central PMCID: PMC4884684.

3. Wang M, Tulman DB, Sholl AB, Kimbrell HZ, Mandava SH, Elfer KN, Luethy S, Maddox MM, Lai W, Lee BR, Brown JQ. Gigapixel surface imaging of radical prostatectomy specimens for comprehensive detection of cancer-positive surgical margins using structured illumination microscopy. Sci Rep. 2016 Jun 3;6:27419. doi: 10.1038/srep27419. PubMed PMID: 27257084; PubMed Central PMCID: PMC4891779.

4. Feibus AH, Levy J, McCaslin IR, Doucet ME, Sholl AB, Moparty K, Thomas R, Sartor O, Silberstein JL. Racial variation in prostate needle biopsy templates directed anterior to the peripheral zone. Urol Oncol. 2016 May 4. pii: S1078-1439(16)30002-3. doi: 10.1016/j.urolonc.2016.03.017. [Epub ahead of print] PubMed PMID: 27155916.

5. Moore RF, Sholl AB, Kidd L, Al-Qurayshi Z, Tsumagari K, Emejulu OM, Kholmatov R, Friedlander P, Abd Elmageed ZY, Kandil E. Metadherin Expression is Associated with Extrathyroidal Extension in Papillary Thyroid Cancer Patients. Ann Surg Oncol. 2016 May 4. [Epub ahead of print] PubMed PMID: 27146414.

6. Kimbrell HZ, Sholl AB, Ratnayaka S, Japa S, Lacey M, Carpio G, Bhatia P, Kandil E. BRAF Testing in Multifocal Papillary Thyroid Carcinoma. Biomed Res Int. 2015;2015:486391. doi: 10.1155/2015/486391. Epub 2015 Sep 13. PubMed PMID: 26448939; PubMed Central PMCID: PMC4584030.

7. Wang M, Kimbrell HZ, Sholl AB, Tulman DB, Elfer KN, Schlichenmeyer TC, Lee BR, Lacey M, Brown JQ. High-Resolution Rapid Diagnostic Imaging of Whole Prostate Biopsies Using Video-Rate Fluorescence Structured Illumination Microscopy. Cancer Res. 2015 Oct 1;75(19):4032-41. doi: 10.1158/0008-5472.CAN-14-3806. Epub 2015 Aug 17. PubMed PMID: 26282168; PubMed Central PMCID: PMC4592466.

8. Tsumagari K, Abd Elmageed ZY, Sholl AB, Friedlander P, Abdraboh M, Xing M, Bolares AH, Kandil E. Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer. Cancer Lett. 2015 Nov 1;368(1):46-53. doi: 10.1016/j.canlet.2015.07.011. Epub 2015 Jul 21. PubMed PMID: 26208433; PubMed Central PMCID: PMC4555189.

9. Sholl AB, Aisner DL, Behbakht K, Post MD. Novel TP53 gene mutation and correlation with p53 immunohistochemistry in a mixed epithelial carcinoma of the endometrium. Gynecol Oncol Case Rep. 2012 Oct 26;3:11-3. doi: 10.1016/j.gynor.2012.10.005. eCollection 2012. PubMed PMID: 24371653; PubMed Central PMCID: PMC3862336.

Dept. of Pathology & Laboratory Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 504-988-5224 tulpath@tulane.edu